This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
NeoGenomics, Inc.
Q22020
7/28/2020
Doug Van Oort
President and CEO
The first sample population, the positivity rate has been running in the high single digits. and so I think for us you know pooling is not appropriate at this time but certainly that capability exists and I think when positivity rates come down to a level where you know it makes more sense to pool then that's something that we could potentially do and I know a number of the other labs where they can are contemplating pooling, and I think it will increase the capacity of COVID-19 testing, and I think it's a good approach.
Bruce Jackson
Analyst at Benchmark Company
All right, that's helpful. Thank you very much. I'll hop back in queue.
Operator
Conference Operator
For our next question, we'll return to Steve Unger with Needham. Please go ahead.
You're reading a preview of the NEO Q2 2020 earnings call.
Free account.
Disclaimer